Elanco Animal Health (NASDAQ:ELAN) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.04-1.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.09. The company issued revenue guidance of $3.08-3.12 billion, compared to the consensus revenue estimate of $3.11 billion.
NASDAQ:ELAN opened at $29.19 on Friday. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61. The stock has a 50-day simple moving average of $32.86 and a 200 day simple moving average of $31.93.
Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.02. The firm had revenue of $781.60 million for the quarter, compared to the consensus estimate of $781.49 million. The company’s revenue was up 1.5% compared to the same quarter last year.
A number of research analysts recently issued reports on ELAN shares. Guggenheim started coverage on Elanco Animal Health in a report on Wednesday, May 22nd. They set a neutral rating for the company. BMO Capital Markets increased their price objective on Elanco Animal Health from $32.00 to $35.00 and gave the stock a market perform rating in a report on Friday, May 10th. Zacks Investment Research downgraded Elanco Animal Health from a buy rating to a hold rating in a report on Wednesday, July 10th. Finally, UBS Group upgraded Elanco Animal Health from a sell rating to a neutral rating and decreased their price objective for the stock from $31.00 to $30.00 in a report on Thursday. Nine analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $33.72.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Recommended Story: Do equity income investments outperform growth and income investments?
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.